Fibroblast growth factor-like autoantibodies in plasma from patients with multiple endocrine neoplasia type 1 and prolactinoma.
Zimering
M B
MB
Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, Piscataway 08854, USA.
Katsumata
N
N
Friesen
H G
HG
Eng
J
J
Riley
D J
DJ
Thakker-Varia
S
S
Marx
S J
SJ
Ezzat
S
S
D000818:Animals; D001323:Autoantibodies / Q000097:blood*; D002417:Cattle; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000187:drug effects; D016222:Fibroblast Growth Factor 2 / Q000276:immunology*; D006801:Humans; D018761:Multiple Endocrine Neoplasia Type 1 / Q000276:immunology*; D010911:Pituitary Neoplasms / Q000276:immunology*; D015175:Prolactinoma / Q000276:immunology*; D011817:Rabbits; D011994:Recombinant Proteins / Q000276:immunology
D001323:Autoantibodies; D011994:Recombinant Proteins; D016222:Fibroblast Growth Factor 2